We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Effects of Fenofibrate on Adipocytokine Levels In Hypertriglyceridemic Patients

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00745407
First Posted: September 3, 2008
Last Update Posted: September 3, 2008
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
Gachon University Gil Medical Center
  Purpose
Fenofibrate increases adiponectin levels, but reduces leptin levels

Condition Intervention Phase
Hypertriglyceridemia Drug: fenofibrate Phase 4

Study Type: Interventional
Study Design: Intervention Model: Crossover Assignment
Primary Purpose: Treatment

Resource links provided by NLM:


Further study details as provided by Gachon University Gil Medical Center:

Study Start Date: January 2005
Study Completion Date: August 2008
Arms Assigned Interventions
Experimental: fenofibrate 160 mg, placebo Drug: fenofibrate

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   25 Years to 80 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • hypertriglyceridemia

Exclusion Criteria:

  • chronic liver disease
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00745407


Locations
Korea, Republic of
Gil Medical Center
Incheon, Korea, Republic of, 405760
Sponsors and Collaborators
Gachon University Gil Medical Center
  More Information

ClinicalTrials.gov Identifier: NCT00745407     History of Changes
Other Study ID Numbers: GMC 200511
First Submitted: September 2, 2008
First Posted: September 3, 2008
Last Update Posted: September 3, 2008
Last Verified: September 2008

Keywords provided by Gachon University Gil Medical Center:
adipocytokines
insulin sensitivity
hypertriglyceridemic patients

Additional relevant MeSH terms:
Hypertriglyceridemia
Hyperlipidemias
Dyslipidemias
Lipid Metabolism Disorders
Metabolic Diseases
Fenofibrate
Hypolipidemic Agents
Antimetabolites
Molecular Mechanisms of Pharmacological Action
Lipid Regulating Agents